Home > Cashflow Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-2,298 Cr₹-2,780 Cr₹77 Cr₹-1,781 Cr₹-1,651 Cr

What is the latest Cash Flow from Financing Activities ratio of TORRENT PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of TORRENT PHARMACEUTICALS is ₹-2,298 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-2,298 Cr
Mar2024₹-2,780 Cr
Mar2023₹77 Cr
Mar2022₹-1,781 Cr
Mar2021₹-1,651 Cr

How is Cash Flow from Financing Activities of TORRENT PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-2,298 Cr
Negative
Mar2024 ₹-2,780 Cr
Negative
Mar2023 ₹77 Cr
Positive
Mar2022 ₹-1,781 Cr
Negative
Mar2021 ₹-1,651 Cr -

Compare Cash Flow from Financing Activities of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹150,628.6 Cr 0.5% 8.2% 39% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,610.0 Cr -2.1% 13.6% 6.3% Stock Analytics
DIVIS LABORATORIES ₹179,279.0 Cr -2% 6.2% 3.2% Stock Analytics
CIPLA ₹114,469.0 Cr 1.3% 9.5% -4.6% Stock Analytics
DR REDDYS LABORATORIES ₹110,955.0 Cr 0.6% 1% 8.8% Stock Analytics
MANKIND PHARMA ₹99,864.1 Cr -6.4% 6.7% -3% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

0.5%

8.2%

39%

SENSEX

1.1%

-2.1%

-6.4%


You may also like the below Video Courses